What Researchers Did
Researchers conducted an online survey among Dutch oral and maxillofacial surgeons to assess their use and perception of hyperbaric oxygen therapy in treating osteoradionecrosis.
What They Found
Of 53 units contacted, 49 (92%) responded. Head and neck cancer units (Group 1) treated more osteoradionecrosis patients and referred 93% for hyperbaric oxygen therapy, compared to 84% in non-HNC units (Group 2). Group 1 rated hyperbaric oxygen therapy efficacy at 3.7 out of 5, while Group 2 rated it at 3.2.
What This Means for Canadian Patients
Canadian patients with osteoradionecrosis may benefit from receiving care at specialized head and neck cancer centers, where hyperbaric oxygen therapy referrals might be more common. This centralization could lead to more consistent treatment approaches for this complex condition.
Canadian Relevance
This study was conducted in the Netherlands and does not have a direct Canadian connection. However, its findings on the centralization of care for osteoradionecrosis and the use of hyperbaric oxygen therapy could inform similar discussions within the Canadian healthcare system.
Study Limitations
A key limitation of this study is its reliance on self-reported survey data, which may not fully reflect actual clinical practice or patient outcomes.